Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kovitz Investment Group Partners LLC lifted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 70,569 shares of the biopharmaceutical company’s stock after purchasing an additional 923 shares during the quarter. […]
Blair William & Co. IL decreased its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 471,600 shares of the biopharmaceutical company’s stock after selling 13,310 shares during the quarter. […]
Choreo LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 5,303 shares of the biopharmaceutical company’s stock after buying an additional 142 shares during the period. Choreo LLC’s holdings in Gilead Sciences were worth $397,000 as of its most […]
Letko Brosseau & Associates Inc. trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 970,915 shares of the biopharmaceutical company’s stock after selling 1,925 shares during the period. […]
Pathstone Family Office LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 299.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 52,159 shares of the biopharmaceutical company’s stock after buying an additional 39,094 shares during […]